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Abstract
Background: The generation of energy from glucose is impaired in diabetes and can be compensated by other
substrates like fatty acids (Randle cycle). Little information is available on amino acids (AA) as alternative energy-
source in diabetes. To study the interaction between insulin-stimulated glucose and AA utilization in normal and
diabetic subjects, intraportal hyperinsulinaemic euglycaemic euaminoacidaemic clamp studies were performed in
normal (n = 8) and streptozotocin (120 mg/kg) induced diabetic (n = 7) pigs of ~40-45 kg.
Results: Diabetic vs normal pigs showed basal hyperglycaemia (19.0 ± 2.0 vs 4.7 ± 0.1 mmol/L, P < .001) and at
the level of individual AA, basal concentrations of valine and histidine were increased (P < .05) whereas tyrosine,
alanine, asparagine, glutamine, glutamate, glycine and serine were decreased (P < .05). During the clamp, diabetic
vs normal pigs showed reduced insulin-stimulated glucose clearance (4.4 ± 1.6 vs 16.0 ± 3.0 mL/kg·min, P < .001)
but increased AA clearance (166 ± 22 vs 110 ± 13 mL/kg· min, P < .05) at matched arterial euglycaemia (5-7
mmol/L) and euaminoacidaemia (2.8-3.5 mmol/L). The increase in AA clearance was mainly caused by an increase
in non-essential AA clearance (93.6 ± 13.8 vs 46.6 ± 5.4 mL/kg·min, P < .01), in particular alanine (14.2 ± 2.4 vs
3.2 ± 0.4 mL/kg·min, P < .001). Essential AA clearance was largely unchanged (72.9 ± 8.5 vs 63.3 ± 8.5 mL/kg· min),
however clearances of threonine (P < .05) and tyrosine (P < .01) were increased in diabetic vs normal pigs
(8.1 ± 1.3 vs 5.2 ± 0.5, and 14.3 ± 2.5 vs 6.4 ± 0.7 mL/kg· min, respectively).
Conclusions: The ratio of insulin-stimulated glucose versus AA clearance was decreased 5.4-fold in diabetic pigs,
which was caused by a 3.6-fold decrease in glucose clearance and a 2.0-fold increase in non-essential AA
clearance. In parallel with the Randle concept (glucose - fatty acid cycle), the present data suggest the existence of
a glucose and non-essential AA substrate interaction in diabetic pigs whereby reduced insulin-stimulated glucose
clearance seems to be partly compensated by an increase in non-essential AA clearance whereas essential AA are
preferentially spared from an increase in clearance.
Background
The interaction between glucose and nonesterified fatty
acids (NEFA) for oxidation in tissues or at the whole
body level has been documented in many animal and
human studies [1-3]. The glucose - NEFA cycle was first
described by Randle and coworkers [4]. In essence they
showed that the metabolic relationship between the sub-
strates glucose and NEFA is reciprocal and not depen-
dent. High plasma glucose concentrations promote
glucose oxidation and inhibit NEFA oxidation. Vice
versa, high plasma NEFA concentrations promote NEFA
oxidation and inhibit glucose oxidation. Apart from the
fact that mass action drives the glucose - NEFA cycle,
substrate competition is also mediated by insulin. Insu-
lin stimulates glucose oxidation and inhibits NEFA oxi-
dation. The basic principles of the glucose - NEFA cycle
also seem to apply for glucose and amino acids (AA)
and therefore the existence of a glucose -AA cycle was
proposed [5-8].
The purpose of substrate competition is to meet the
energy demand of the body by oxidation of different
substrates, i.e. glucose, NEFA or AA, depending on the
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availability of the substrates. At fasting, when plasma
glucose, AA, and insulin levels are low, plasma NEFA
levels will increase due to lipolysis from body fat, and
NEFA will be primarily oxidized. After a meal, when
plasma glucose, AA, and insulin levels are high, glucose
and to a lesser extent AA will be oxidized.
In diabetic subjects however, the orchestrating role of
substrate competition to channel energy oxidation
depending on substrate availability is out of balance.
The diabetic state is characterized by hyperglycaemia
and insulin resistance and, as such, the metabolic hand-
ling of substrates like glucose, NEFA and AA is
disturbed. For instance, diabetic subjects are hypergly-
caemic but show impaired (insulin-stimulated) glucose
oxidation and increased NEFA oxidation at elevated
plasma NEFA concentrations [1,9,10]. An increased rate
of NEFA oxidation may thus represent a mechanism to
meet the energy demand of diabetic subjects. There is
inconsistent information whether AA play a role in the
unbalance of substrate competition in diabetic subjects
[11]. Both increased [12,13] and unchanged [14-16] AA
oxidation has been reported in studies with diabetic
patients. The inconsistency may be caused by differences
in study design: severity of diabetes, treatment with
medication or with diets, used substrate methodology
and control over plasma glucose and AA concentrations
during the study, all play a role in the balance of sub-
strate competition in diabetic subjects [11].
The aim of the present study was to characterize and
compare insulin-stimulated glucose and AA utilization
in normal and streptozotocin (STZ) diabetic pigs by
means of the hyperinsulinaemic, euglycaemic, euaminoa-
cidaemic clamp technique (additional file 1), thereby
avoiding differences in substrate fluxes by mass action.
The pig was chosen as animal model for the study of
translational metabolism because of the many similari-
ties between pigs and humans. Both species are of equal
size and they are omnivores with similar food intake
patterns, digestion and metabolism [17,18].
Results
Experiment 1
The insulin-stimulated individual AA clearance rates in 4
normal and 4 diabetic pigs, as calculated from the first
clamp study when using the AA mixure from Table 1 are
presented in Table 2. In diabetic pigs, the clearance rates of
some essential AA like arginine, phenylalanine, threonine
and tyrosine were increased 2-3 fold whereas the clearance
rates of all non-essential AA were increased 2-4 fold.
During the clamp studies in diabetic pigs the steady
state plasma AA concentrations were compared to the
corresponding preclamp (basal) AA concentrations (data
not shown) in order to adjust the AA mixture to the
diabetic status. After each of the 3 clamp studies in
diabetic pigs, the AA mixture was further finetuned to
optimally meet the utilization rates per individual AA in
diabetic pigs. The final AA mixture for diabetic pigs is
presented in Table 3.
Experiment 2
Diabetic pigs (n = 7) versus normal pigs (n = 8) showed
basal hyperglycaemia (Tables 4 and 5, P < .001), reduced
Table 1 Tailor-made mixture of 20 amino acids (g/L)
designed for infusion during the hyperinsulinaemic
euglycaemic euaminoacidaemic clamp in normal pigs
Arginine, 3.44 Methionine, 1.56 Valine, 3.68 Glutamine,
6.71
Histidine-HCl,
2.00
Phenylalanine,
2.44
Alanine, 4.30 Glutamate,
4.77
Isoleucine, 3.01 Threonine, 2.87 Asparagine,
1.70
Glycine, 7.26
Leucine, 5.39 Tryptophan, 0.90 Aspartate, 0.23 Proline, 4.56
Lysine-HCl 3.59 Tyrosine, 2.29 Cysteine, 0.58 Serine, 3.50
Total amino acid concentration is 65 g/L. Essential amino acids are ARG
through VAL. Non-essential amino acids are ALA through SER.
Table 2 Insulin-stimulated amino acid clearance rates
during the steady state phase of the hyperinsulinaemic
euglycaemic euaminoacidaemic clamp in 4 normal and
4 diabetic pigs in experiment 1, when both normal and
diabetic pigs were infused with an amino acid mixture
(Table 1) designed for normal pigs
Plasma amino acid Normal pigs
(mL/kg·min )
Diabetic pigs
(mL/kg·min)
Essential:
Arginine 4.3 ± 0.8 10.4 ± 2.3*
Histidine 4.0 ± 0.8 4.2 ± 0.5
Isoleucine 5.2 ± 0.9 5.5 ± 1.6
Leucine 5.9 ± 0.9 6.8 ± 1.2
Lysine 5.6 ± 1.2 6.9 ± 0.5
Methionine 9.2 ± 1.1 16.3 ± 2.0
Phenylalanine 5.8 ± 0.8 10.2 ± 1.6*
Threonine 4.5 ± 0.4 8.9 ± 0.8‡
Tryptophan 2.1 ± 0.3 4.3 ± 1.2
Tyrosine 5.6 ± 0.6 19.8 ± 5.5*
Valine 2.3 ± 0.3 2.5 ± 0.7
Non-essential:
Alanine 2.8 ± 0.2 10.7 ± 2.8*
Asparagine 6.5 ± 0.6 15.0 ± 1.9†
Aspartate 1.7 ± 0.2 4.8 ± 1.1*
Cysteine 2.4 ± 0.3 5.8 ± 1.1*
Glutamine 1.7 ± 0.1 5.1 ± 1.3*
Glutamate 4.1 ± 0.4 14.3 ± 2.1†
Glycine 2.3 ± 0.3 6.6 ± 1.6*
Proline 3.9 ± 0.4 6.9 ± 0.9*
Serine 5.3 ± 0.6 14.2 ± 3.1*
Mean ± SEM, * P < .05, † P < .01 and ‡ P < .001 compared to normal pigs.
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plasma concentrations of total AA and increased plasma
concentrations of urea (Tables 4 and 5, both P < .05)
and at the level of individual AA (Figure 1), some essen-
tial AA concentrations were increased (valine and histi-
dine, P < .05) whereas one essential AA (tyrosine, P <
.05) and the non-essential AA alanine, asparagine, gluta-
mine, glutamate, glycine and serine were decreased (P <
.05).
In normal pigs, at steady state during the clamp study
with the tailor made AA mixture for normal pigs (Table
1), plasma insulin concentrations were increased
approximately 4-fold (P < .001) over preclamp concen-
trations whereas the concentrations of glucose, lactate,
total AA, urea and all individual AA (less than 15%) did
not change significantly (Tables 4 and 6). The coeffi-
cients of variation of individual AA concentrations were
less than 21% in the preclamp situation and less than
12% in the steady state situation.
In diabetic pigs, at steady state during the clamp study
with the tailor made AA mixture for diabetic pigs
(Table 3), plasma insulin concentrations were increased
approximately 5-fold (P < .001) over preclamp concen-
trations, plasma glucose concentrations were reduced to
the euglycaemic range and the concentrations of lactate,
total AA, urea and all individual AA did not change sig-
nificantly (Tables 5 and 7). The coefficients of variation
of individual AA concentrations were less than 15% in
the preclamp situation and less than 11% in the steady
state situation.
The insulin-stimulated individual AA clearance rates
in normal and diabetic pigs, are presented in Table 8. In
diabetic pigs, the clearance rates of the essential AA
threonine and tyrosine were increased approximately
2-fold and the clearance rates of the non-essential AA
alanine, asparagine, glutamate and proline were
increased 2-4 fold. The corresponding %-change in indi-
vidual AA clearance rates from the normal to the dia-
betic status is depicted in Figure 2. When the AA
clearance rates are subdivided in total AA, essential AA
and non-essential AA (Figure 3), the clearance rates of
total AA (166 ± 22 vs 110 ± 13 mL/kg·min, P < .05) and
non-essential AA (93.6 ± 13.8 vs 46.6 ± 5.4 mL/kg·min
(P < .01) were increased in diabetic vs normal pigs.
Essential AA clearance was largely unchanged (72.9 ±
8.5 vs 63.3 ± 8.5 mL/kg·min). Glucose clearance rate
(Figure 3) was reduced approximately 4-fold in diabetic
vs normal pigs (4.4 ± 1.6 vs 16.0 ± 3.0 mL/kg·min, P <
.001). Taken together, the ratio of insulin-stimulated
glucose versus AA clearance was decreased 5.4-fold in
diabetic pigs, which was caused by a 3.6-fold decrease in
glucose clearance and a 2.0-fold increase in non-essen-
tial AA clearance.
Discussion
This study demonstrates that in diabetic pigs insulin
resistance for glucose utilization is accompanied by
insulin hypersensitivity for non-essential AA utilization.
In parallel with the Randle concept (glucose - NEFA
cycle), the present data suggest the existence of a glu-
cose - non-essential AA substrate interaction in diabetic
pigs whereby reduced insulin-stimulated glucose clear-
ance seems to be compensated by increased non-essen-
tial AA clearance.
Insulin resistance for glucose metabolism in diabetic
subjects has been argued to be a primary metabolic
defect caused by glucose and lipid toxicity [1,17] and
Table 3 Tailor-made mixture of 20 amino acids (g/L)
designed for infusion during the hyperinsulinaemic
euglycaemic euaminoacidaemic clamp in diabetic pigs
Arginine, 2.78 Methionine, 1.85 Valine, 3.39 Glutamine,
3.29
Histidine-HCl,
2.47
Phenylalanine,
2.34
Alanine, 6.46 Glutamate,
4.32
Isoleucine, 3.28 Threonine, 2.85 Asparagine,
2.39
Glycine, 5.31
Leucine, 6.03 Tryptophan, 0.53 Aspartate, 0 Proline, 6.20
Lysine-HCl 5.42 Tyrosine, 2.85 Cysteine, 0.77 Serine, 2.49
Total amino acid concentration is 65 g/L. Essential amino acids are ARG
through VAL. Non-essential amino acids are ALA through SER.
Table 4 Plasma insulin, glucose, lactate, total amino acids
and urea concentrations are shown at preclamp (basal)
and at steady state during the hyperinsulinaemic
euglycaemic euaminoacidaemic clamp in 8 normal pigs
infused with an AA-mixture (Table 1) designed for
normal pigs
Plasma concentration Preclamp (basal) Steady state clamp
Insulin (mU/L) 7 ± 3 25 ± 4
Glucose (mmol/L) 4.7 ± 0.1 5.0 ± 0.2
Lactate (mmol/L) 0.7 ± 0.1 0.8 ± 0.1
Total amino acids (mmol/L) 3.5 ± 0.1 3.5 ± 0.1
Urea (mmol/L) 2.9 ± 0.2 2.6 ± 0.2
Means ± SEM.
Table 5 Plasma insulin, glucose, lacate, total amino acids
and urea concentrations are shown at preclamp (basal)
and at steady state during the hyperinsulinaemic
euglycaemic euaminoacidaemic clamp in 7 diabetic pigs
infused with an AA-mixture (Table 3) designed for
diabetic pigs
Plasma concentration Preclamp (basal) Steady state clamp
Insulin (mU/L) 5 ± 4 26 ± 6
Glucose (mmol/L) 19.0 ± 2.0 6.8 ± 0.7
Lactate (mmol/L) 0.7 ± 0.1 1.2 ± 0.4
Total amino acids (mmol/L) 2.9 ± 0.1 2.8 ± 0.1
Urea (mmol/L) 5.1 ± 0.5 4.7 ± 0.5
Means ± SEM.
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insulin hypersensitivity for non-essential AA clearance,
as shown in the present study, seems therefore a sec-
ondary response, probably a compensatory mechanism
to warrant sufficient energy supply to body tissues of
diabetic subjects.
It has previously been shown that substrate competi-
tion, apart from glucose - NEFA, can take place between
glucose and AA. Infusion of an AA mixture reduced
insulin-stimulated glucose disposal, and more specifi-
cally glucose oxidation, in healthy man [2,5,8]. Theoreti-
cally the reduction in glucose oxidation was caused by
increased AA oxidation. In our study with diabetic pigs,
the low glucose utilization rate coincided with a high
utilization rate of non-essential AA. Plasma urea con-
centrations remained high during the clamp studies in
diabetic pigs which suggests that AA oxidation was not
inhibited by insulin. Therefore, the increase in non-
essential AA clearance in diabetic pigs most likely
reflects increased AA oxidation.
Glucose and amino acid utilization in normal and diabetic
pigs
In the present study, nutrient utilization was expressed
as nutrient clearance in mL/kg·min. Another approach
is to express nutrient utilization as mg/kg·min. This is
valid for glucose and total AA because nutrient
utilization rates were determined at matched plasma
glucose and AA concentrations (euglycaemia and near
euaminoacidaemia), and therefore the masses of glucose
and AA which were utilized by the body can be directly
compared between normal and diabetic pigs. The insulin-
stimulated net utilization of glucose (14.2 ± 2.3 mg/kg·
min, i.e. ~920 g/day) was 8.4-times greater than the net
utilization of AA (1.7 ± 0.2 mg/kg· min, i.e. ~110 g/day)
in normal pigs. This is largely in accordance with our
previous observations [19] where we found a ratio of
~10:1 in the net utilization of glucose compared to AA in
normal pigs. In diabetic pigs however, the insulin-stimu-
lated net utilization of glucose (4.6 ± 1.6 mg/kg· min, i.e.
~265 g/day) was almost equal to the net utilization of AA
(3.4 ± 1.1 mg/kg· min, i.e. ~196 g/day). When transform-
ing the net utilization rates to generation of gross energy
from nutrients, the following calculation can be made:
The combustion energy (KJ/g substrate) and net ATP
production (mol/g substrate) for glucose vs AA vs NEFA
are 15.6 and 0.211 vs 22.6 and 0.218 vs 38.2 and 0.504,
respectively [20]. This implies that the 2-fold increase
(from 1.7 to 3.4 mg/kg·min ) in AA utilization in diabetic
pigs does not fully compensate for the 3.1-fold decrease
(from 14.2 to 4.6 mg/kg·min ) in glucose utilization in
terms of energy transfer. Energy content of glucose and
AA is similar and therefore it can be concluded that the
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remainder of energy compensation in diabetic pigs must
come from increased NEFA utilization to fill the existing
energy gap (3.1 divided by 2 = 1.55) between a 3.1-fold
decrease in glucose utilization and a 2-fold increase in
AA utilization. Energy content of NEFA is approximately
2-fold higher compared to glucose and therefore it can
be calculated that NEFA utilization must have been
increased 1.275-fold (1.55 divided by 2) under the present
experimental conditions in diabetic pigs.
Essential and non-essential amino acid utilization in
diabetic pigs
Adult pigs require a core of nine AA for maintenance
and productive purposes which are called “essential”. In
young growing pigs, like the pigs used in the present
study, two additional AA are considered (conditionally)
essential: arginine and tyrosine. Other amino acids
which pigs are able to synthesize are termed “non-essen-
tial” [21].
With respect to non-essential AA, alanine is the major
AA utilized by the liver as a substrate for gluconeogen-
esis [22]. The plasma concentration of alanine reflects
the algebraic sum of its release from peripheral tissue
and rates of utilization by the liver for gluconeogenesis.
Plasma alanine concentrations were low in diabetic pigs
indicating that release of alanine is lower than its utiliza-
tion. Our data show that insulin-stimulated alanine utili-
zation was high in diabetic pigs, which fits with the
general observation that gluconeogenesis from alanine is
increased in diabetes [23].
Essential AA were preferentially spared from increased
utilization in diabetic pigs, as shown for phenylalanine
and leucine in previous studies in diabetic humans
[14-16,24]. This may represent a protective mechanism
to maintain body protein integrity. However, the utiliza-
tion rates of two essential AA, threonine and tyrosine,
were increased in diabetic pigs. Threonine, when catabo-
lised, is dehydrated first to alpha-ketobutyrate, which is
Table 6 Individual amino acid concentrations are shown
at preclamp (basal) and at steady state during the
hyperinsulinaemic euglycaemic euaminoacidaemic clamp
in 8 normal pigs infused with an AA-mixture (Table 1)
designed for normal pigs
Plasma amino acid Preclamp
(basal)
(μ mol/L)
Steady state
clamp
(μ mol/L)
Deviation
from basal
VC
(%)
VC
(%)
(%) P-value
Essential:
Arginine 109 ± 4 8 100 ± 4 7 -8
Histidine 46 ± 3 11 50 ± 3 6 9
Isoleucine 111 ± 12 5 94 ± 10 6 -15
Leucine 168 ± 7 4 160 ± 12 5 -5
Lysine 85 ± 6 12 72 ± 6 11 -15
Methionine 27 ± 1 7 25 ± 1 7 -7
Phenylalanine 49 ± 2 8 50 ± 3 5 2
Threonine 121 ± 10 8 121 ± 7 6 0
Tryptophan 39 ± 3 13 43 ± 2 4 10
Tyrosine 56 ± 5 7 53 ± 2 6 -5
Valine 291 ± 28 6 259 ± 13 5 -11
Non-essential:
Alanine 422 ± 28 8 418 ± 34 7 -1
Asparagine 49 ± 4 11 46 ± 3 7 -6
Aspartate 20 ± 2 21 18 ± 1 12 -10
Cysteine 35 ± 4 6 35 ± 3 4 0
Glutamine 551 ± 27 6 585 ± 22 5 6
Glutamate 182 ± 10 9 178 ± 10 10 -2
Glycine 799 ± 32 6 866 ± 33 4 8
Proline 201 ± 12 4 214 ± 7 4 6
Serine 142 ± 6 13 129 ± 8 7 -9
Means ± SEM, VC = coefficient of variation.
Table 7 Individual amino acid concentrations are shown
at preclamp (basal) and at steady state during the
hyperinsulinaemic euglycaemic euaminoacidaemic clamp
in 7 diabetic pigs infused with an AA-mixture (Table 3)
designed for diabetic pigs
Plasma amino acid Preclamp
(basal)
(μ mol/L)
Steady state
clamp
(μ mol/L)
Deviation
From basal
VC
(%)
VC
(%)
(%) P-value
Essential:
Arginine 99 ± 11 6 83 ± 9 8 -16
Histidine 64 ± 6 3 69 ± 5 6 8
Isoleucine 194 ± 39 4 144 ± 25 6 -26
Leucine 242 ± 41 5 214 ± 21 6 -12
Lysine 114 ± 13 8 146 ± 13 6 28
Methionine 23 ± 2 8 27 ± 2 10 17
Phenylalanine 48 ± 4 6 50 ± 3 5 4
Threonine 105 ± 13 6 109 ± 12 7 4
Tryptophan 33 ± 2 7 32 ± 3 7 -3
Tyrosine 39 ± 2 9 39 ± 3 8 0
Valine 507 ± 79 3 363 ± 51 5 -28
Non-essential:
Alanine 158 ± 32 6 180 ± 16 7 14
Asparagine 28 ± 4 15 34 ± 5 10 21
Aspartate 16 ± 3 6 19 ± 5 7 19
Cysteine 28 ± 3 4 34 ± 3 6 21 0.09
Glutamine 375 ± 28 2 357 ± 33 5 -5
Glutamate 90 ± 9 7 96 ± 8 11 7
Glycine 444 ± 72 3 546 ± 57 6 23
Proline 179 ± 13 6 211 ± 12 6 18 0.09
Serine 93 ± 7 8 91 ± 7 8 -2
Means ± SEM. VC = coefficient of variation.
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then converted to propionyl CoA, the precursor of suc-
cinyl CoA. Through threonine metabolism pyruvate is
formed, which enters the Krebs Cycle [25]. Therefore
threonine may compensate for the reduction in glucose-
related energy in diabetes. However, threonine is also
involved in many physiological functions, in particular
those of immune system functionality [20,26], gut muco-
sal repair processes [21] and threonine deficiency inhi-
bits growth and reduces body water content [21],
thereby possibly worsening dehydration in diabetes. Tyr-
osine is the immediate precursor for production of the
neurotransmitters and hormones dopamine, adrenaline,
noradrenaline, thyroxine and the antioxidant melanin,
and as such involved in the regulation of metabolism
and inhibition of inflammation [20,26]. Abnormalities in
metabolism and inflammation are characteristic features
of diabetes [27]. A deficiency in some essential AA like
threonine and tyrosine may therefore contribute to the
development of secondary complications and the health
problems of diabetic patients, i.e. increased susceptibility
to infections and reduced nervous system functionality.
Infused amino acid mixtures
It can be argued that the chosen composition of the
infused AA mixture played a major role in the balance
between glucose and AA utilization. There are two argu-
ments against this assumption. First, the composition of
the AA mixture was determined by the endogenous AA
fluxes in the pig. Basal plasma AA concentrations were
kept constant at steady state of the clamp and this
approach determined the composition of the AA mix-
ture. Second, two different AA mixtures were used in the
present study. One AA mixture (Table 1) contained 48%
essential and 52% non-essential AA, the other AA mix-
ture (Table 3) contained 52% essential and 48% non-
essential AA. Both AA mixtures yielded comparable
results with respect to the increase in clearance rates of
non-essential AA in diabetic pigs. Minor differences were
observed at the level of some individual AA like arginine,
phenylalanine, cysteine, glutamine, glycine and serine.
Therefore the conclusion with respect to the existence of
a glucose - non-essential AA substrate cycle in diabetic
pigs is valid for both AA mixtures, i.e. a mixture which
fits normal pigs (experiment 1) and a mixture which fits
diabetic pigs (experiment 2).
Limitations of the study
Data were collected by means of the hyperinsulinaemic
euglycaemic euaminoacidaemic clamp technique which
reflects the nutrient uptake capacity of the body. Linking
these data to the Randle cycle is a debatable issue
because oxidation of nutrients was not measured in the
present study. Referring to the plasma urea concentra-
tions as a crude measure of AA oxidation is only partly
valid. During the clamp, nutrients disappear from the
blood into tissues and the intracellular fate of these
nutrients is unknown. AA could be used for protein
synthesis or oxidation. Young pigs have a high capacity
for growth and therefore it is expected that a large por-
tion of the infused AA is used for protein accretion and
not for oxidation. It is uncertain whether the capacity
for protein accretion is unaltered during hyperinsulinae-
mic euglycaemic euaminoacidaemic conditions in dia-
betic pigs. However, there are some indications that this
is the case: 1) Lysine is the first limiting AA for protein
accretion and body weight gain in pigs [28]. In the pre-
sent study, lysine clearance was not different in diabetic
and control pigs. 2) Diabetes seems not to be associated
with insulin resistance for protein synthesis and protein
degradation [29,30]. 3) At identical dietary energy
intake, average weekly growth of control pigs was ~4 kg
whereas growth of diabetic pigs was ~1 kg with an urin-
ary glucose excretion of ~2 kg. This is in line with our
previous observations [17]. This suggests that dietary
energy efficacy is reduced ~4-fold in hyperglycaemic
diabetic pigs which seems to be mainly caused by loss
Table 8 Insulin-stimulated amino acid clearance rates
during the steady state phase of the hyperinsulinaemic
euglycaemic euaminoacidaemic clamp in 8 normal and
7 diabetic pigs
Plasma amino acid Normal pigs
(mL/kg·min)
Diabetic pigs
(mL/kg·min)
Essential:
Arginine 5.2 ± 0.5 7.2 ± 1.4
Histidine 5.3 ± 0.7 5.7 ± 0.5
Isoleucine 7.0 ± 1.3 6.2 ± 0.7
Leucine 7.3 ± 1.0 7.3 ± 0.7
Lysine 7.4 ± 0.9 7.2 ± 1.1
Methionine 11.4 ± 1.4 16.1 ± 2.4
Phenylalanine 8.2 ± 1.3 9.3 ± 1.1
Threonine 5.2 ± 0.5 8.1 ± 1.3*
Tryptophan 2.7 ± 0.3 3.0 ± 0.6
Tyrosine 6.4 ± 0.7 14.3 ± 2.5†
Valine 3.6 ± 0.8 2.8 ± 0.4
Non-essential:
Alanine 3.2 ± 0.4 14.2 ± 2.4‡
Asparagine 9.5 ± 1.8 22.1 ± 5.4*
Aspartate 2.0 ± 0.2 0 ± 0
Cysteine 4.1 ± 0.8 6.7 ± 1.2
Glutamine 2.1 ± 0.2 2.4 ± 0.6
Glutamate 5.0 ± 0.6 10.6 ± 1.3‡
Glycine 2.9 ± 0.3 5.2 ± 1.5
Proline 4.9 ± 0.5 8.6 ± 0.9†
Serine 6.5 ± 0.7 9.5 ± 1.9
Normal pigs were infused with an amino acid mixture (Table 1) designed for
normal pigs and diabetic pigs were infused with an amino acid mixture
(Table 3) designed for diabetic pigs.
Mean ± SEM, * P < .05, † P < .01 and ‡ P < .001 compared to normal pigs.
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of energy via the urine. Under the present euglycaemic
clamp conditions however, when urinary glucose loss is
negligible, the capacity for growth seems similar in con-
trol and diabetic pigs.
Taken together, the interpretation of the data with
respect to the Randle cycle should be read with the
reservation in mind that oxidation was not measured in
the present study.
Conclusions
Studies so far have established that excess exogenous
AA infusion competes with glucose for uptake by insu-
lin-sensitive tissues in healthy individuals [2,5,8].
Whether this substrate competition is in effect in dia-
betic subjects was the research focus of the present
study. We conclude that a glucose - AA cycle exists in
diabetic subjects but the nature of substrate competi-
tion seems different from healthy subjects. Given the
fact that glucose uptake is suppressed and considered
to be the primary metabolic defect in diabetic subjects,
the increase in non-essential AA uptake seems a com-
pensatory mechanism to provide the body with suffi-
cient energy. Therefore the glucose - AA cycle in
diabetic subjects may be designated as “compensatory”
in stead of “competitive” with regard to the substrate
interaction, being a glucose - non essential AA sub-
strate compensation.
Methods
The principles of laboratory animal care (NIH publica-
tion no. 85-23, revised 1985) were followed. Experimen-
tal protocols describing the management, surgical
procedures, and animal care were reviewed and
approved by the ASG-Lelystad Animal Care and Use
Committee (Lelystad, The Netherlands).
Animals, housing, diets and surgery
Twenty-four crossbred barrows (Dutch Landrace ×
Yorkshire × Finnish Landrace) with an initial body
weight of 30-35 kg were used in this study. Two weeks
before surgery the pigs were kept in specially designed
metabolic pens (1.15 × 1.35 m) and adapted to the
light/dark cycle (lights on at 0500 h and off at 1900 h)
and the feeding schedule. The pigs were fed a commer-
cial pig diet (5% crude fat, 16% crude protein, 41%
starch and sugars, 20% non-starch polysaccharides, 6%
ash and 12% water; Startbrok; Agrifirm, Meppel, The
Netherlands). The pigs were fed twice daily (at 0600 h
and 1600 h) at a feeding level of 2.8 times maintenance
requirements for metabolizable energy (ME). This corre-
sponded with a feeding level of 1109 kJ ME/kg BW0.75
(metabolic weight of the pig) which is close to the ad
libitum feeding level for pigs [28]. Water was always
available ad libitum.
Pigs were provided with 3 permanent blood vessel
catheters in the jugular vein, carotid artery and portal
vein, as previously described [19,31]. During the period
between surgery and the clamp study (two weeks post-
surgery), the pigs were habituated to the blood sampling
procedure. The carotid artery was used for blood sam-
pling and the jugular vein catheter was used as a back-
up in case of a malfunctioning arterial catheter. The
portal vein catheter was used for the infusion of fluids
during the hyperinsulinaemic euglycaemic euaminoaci-
daemic clamp experiments. During the blood sampling
procedure, the catheters were flushed with physiological
saline and sealed off with physiological saline containing
5 IU heparin per mL. To avoid activation of lipoprotein
lipase by heparin, care was taken that minimal amounts
of heparin entered the blood stream and from experi-
ence we know that this sampling procedure does not
affect plasma NEFA concentrations.
Normal and diabetic pigs
After surgery, half of the pigs were treated with strepto-
zotocin (STZ; Pharmacia & Upjohn Company, Kalama-
zoo, MI., 120 mg/kg) as described previously [17]. Two
weeks thereafter, 1 pig showed fasting plasma glucose
concentrations <10 mmol/L and was excluded from the
study. Other diabetic pigs remained non-ketotic
throughout the study as determined by analysis of acet-
oacetic acid in urine.
Hyperinsulinaemic euglycaemic euaminoacidaemic clamp
technique
The intraportal hyperinsulinaemic euglycaemic euami-
noacidaemic clamp technique was used to quantitate
insulin-stimulated net utilization of plasma glucose and
of individual AA in pigs [19,31-33]. Nutrient utilization
was expressed as nutrient clearance (infusion rate of
nutrients (in mol/kg·min ) divided by the plasma nutri-
ent concentration (in mol/mL). When comparing blood
nutrient fluxes at different nutrient concentrations in
blood (in particular for some of the 20 AA), the calcula-
tion of nutrient clearance normalizes the nutrient fluxes
for differences in plasma nutrient concentrations,
thereby eliminating the mass action effect of concentra-
tion on flux and thus exposing whole body nutrient uti-
lization at identical blood nutrient concentrations.
By portal infusion the physiological route of appear-
ance of insulin (secreted from the pancreatic beta-cells),
glucose and AA (from the intestine after food intake) is
mimicked. Concentrations of insulin, glucose and AA
are high in the portal vein during the intraportal clamp
studies, and therefore the liver will be exposed to phy-
siologically correct concentrations of insulin, glucose
and AA. This allows the liver to fully exert its metabolic
control function in the body. For instance, most
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glucogenic AA (mainly alanine) are metabolized by the
liver whereas branched-chain AA (valine, (iso)leucine)
are metabolized in peripheral tissues. Considering the
foregoing argumentation, it is important to impose a
correct portal - peripheral gradient for insulin, glucose
and all individual AA, resulting in a proper simulation
of whole body insulin-stimulated rates of glucose and
AA.
Insulin (Actrapid MC, porcine monocomponent,
Novo, Copenhagen, Denmark), D-glucose (Merck,
Darmstadt, Germany) and a tailor-made mixture of 20
AA (Sigma, Zwijndrecht, The Netherlands) (Tables 1
and 3) were prepared as sterile solutions and passed
through a 0.22 μ m Millipore filter into sterile contain-
ers before use. Insulin was diluted in a saline solution
containing 3% pig plasma in order to avoid sticking of
insulin to the plastic containers and tubings. D-glucose
and the AA were dissolved in water.
In the basal state, at 0600 h and 0615 h, two hepari-
nized blood (10 mL) samples were collected. At 0630 h,
hyperinsulinaemic euglycaemic euaminoacidaemic clamp
experiments were started by a prime (26 mU/kg)-con-
tinuous (1.5 mU/kg·min) intraportal infusion of insulin
for 6 hours via the portal catheter. Due to the insulin
infusion, plasma glucose and AA concentrations
declined and a variable intraportal infusion of a 33% D-
glucose solution (330 g/L) and an AA solution (65 g/L)
(Tables 1 and 3) were started and the infusion rates
were adjusted every 10 (glucose solution) and 20 min-
utes (AA solution) to maintain the plasma glucose and
phenylalanine concentrations at euglycaemic (5-7 mmol/
L) and euaminoacidaemic (2.8-3.5 mmol/L) levels.
Steady state conditions for plasma glucose and phenyla-
lanine concentrations and the infusion rates of glucose
and AA were achieved within 5 hours after initiation of
the hyperinsulinaemic clamp and steady state calcula-
tions for whole body glucose and AA utilization were
carried out during the last 40 minutes of the clamp (t =
320, 340 and 360 minutes). At 320, 340 and 360 min-
utes, blood (10 mL) samples were collected in hepari-
nized tubes for measurement of plasma insulin, glucose,
lactate, 20 individual AA, and urea concentrations.
Experiments
In total, 12 non-diabetic (normal) and 11 diabetic pigs
were studied with the hyperinsulinaemic euglycaemic
euaminoacidaemic clamp technique in 2 experiments.
In experiment 1, normal (n = 4) and diabetic pigs (n =
4) were infused with insulin, glucose and an AA mixture
specifically designed for normal pigs (Table 1). The
infused, tailor made, AA mixture (Table 1) contained 20
AA in concentrations which were in proportion to the
utilization rates per individual AA in the normal pig. By
experience, this AA mixture was defined in previous
experiments [19,31,32] allowing us to study insulin sen-
sitivity in the absence of hypo- or hyperaminoacidaemia
for individual AA. After data collection and calculation
of the insulin-stimulated AA clearance rates in normal
and diabetic pigs, the AA mixture was adjusted to dia-
betic pigs (for the use in the second experiment) in the
following way:
AA concentration in the adjusted mixture =
AA concentration in the used mixture × preclamp plasma AA concentration
steady state clamp plasma AA concentration
To further fine-tune and adjust the AA mixture to the
diabetic status the diabetic pigs were re-used for clamp
studies twice more (after 2 week intervals). This led to a
near-optimal AA mixture (Table 3) which contained 20
AA in concentrations which are in proportion to the
utilization rates of individual AA in the diabetic pig.
In experiment 2, normal pigs (n = 8) were infused
with insulin, glucose and an AA mixture specifically
designed for normal pigs (Table 1) and the diabetic pigs
(n = 7) were infused with insulin, glucose and an AA
mixture specifically designed for diabetic pigs (Table 3),
as calculated in experiment 1.
Plasma and urine analyses
Blood samples collected in heparinized (150 USP. U.
Lithium Heparin) or EDTA (ethylenediaminetetraacetic
acid, 0.47 mol/L) tubes (10 mL Venoject, Terumo, Leu-
ven, Belgium) were immediately chilled at 0°C on water
with ice, and centrifuged at 4°C for 10 minutes at 3000
rpm. Plasma aliquots were stored at -80°C for later
analyses.
Plasma insulin concentration was measured using a
Delfia assay (test kit by Perkin Elmer Life Sciences Trust
by Wallac Oy, Turku, Finland). This specific pig insulin
assay was validated using pig insulin standards, as indi-
cated before [17,19,31,32]. Plasma glucose and lactate
concentrations were analyzed with a blood autoanalyzer
of Radiometer (ABL and AML, Copenhagen, Denmark).
Plasma urea concentration was analyzed by the method
described by Gutmann & Bergmeyer [34].
Plasma tryptophan and phenylalanine concentrations
were measured by reversed-phase liquid chromatogra-
phy (HPLC System Gold, Beckman, Fullerton, CA, USA)
using a C18 (Hypersil) column (Alltech, Deerfield, IL,
USA), and detected with a fluorescence detector at 217
nm [35]. For rapid plasma phenylalanine determination
during the clamp studies, blood samples (0.5 mL) were
immediately centrifuged in a microcentrifuge for 0.5
min, 0.1 mL of a 8% salicylic acid (SSA) solution was
added to 0.1 mL plasma, mixed thoroughly, centrifuged
in a microcentrifuge for 0.5 minute and 0.02 mL of
supernatant was injected in the reversed-phase HPLC
system. Retention time for phenylalanine and tryptophan
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analyses were 4 and 6 minutes respectively. The concen-
trations of AA in plasma (except for tryptophan) were
analyzed as described previously [35].
Ketones (acetoacetic acid) were determined in fresh
urine by a reagent strip test (Ketostix, Bayer Diagnostics,
Mijdrecht, The Netherlands).
Statistical analyses
Each pig was an experimental unit. Results are
expressed as means ± SEM and the criterion of statisti-
cal significance was set at P < .05. The data were sub-
jected to the unpaired student’s t-test of Genstat 5 [36]
for determination of differences between two groups,
respectively.
Additional material
Additional file 1: The hyperinsulinaemic euglycaemic
euaminoacidaemic clamp in a pig. A photograph showing blood
sampling in a conscious pig.
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